Table 2.

Cardiometabolic profile in patients with acute ischemic strokes regarding statins therapy compared with the controls

Variables	Controls (n=29)	Statins (n=23)	Nonstatins (n=35)	I	II	III	ANOVA
BMI (kg/m2)	32.69±4.91	34.81±6.84	35.66±6.28	NS	NS	NS	0.14
SBP (mmHg)	123.48±9.21	141.75±10.81	145.72±11.68	0.001	0.001	NS	0.001
DBP (mmHg)	71.89±5.86	91.94±7.51	95.79±9.73	0.001	0.001	NS	0.001
MAP (mmHg)	89.09±7.36	108.54±9.71	112.43±9.74	0.001	0.001	NS	0.001
PP (mmHg)	51.59±5.84	49.81±4.93	49.93±4.77	NS	NS	NS	NS
TC (mg/dL)	177.92±11.65	189.56±12.82	233.81±15.89	0.009	0.001	0.001	0.001
TG (mg/dL)	132.82±9.41	178.92±11.85	212.69±18.63	0.001	0.001	0.001	0.001
HDL-c (mg/dL)	49.85±7.67	41.91±6.81	34.81±4.91	0.001	0.001	0.001	0.001
LDL-c (mg/dL)	101.50±8.47	111.90±9.85	156.50±17.95	0.008	0.001	0.001	0.001
VLDL (mg/dL)	26.56±6.59	35.78±7.54	42.53±6.49	0.001	0.001	0.001	0.001
Non-HDL-c (mg/dL)	128.07±8.09	147.65±11.76	199.00±17.42	0.001	0.001	0.001	0.001
AI	0.066±0.002	0.270±0.003	0.426±0.003	0.001	0.001	0.03	0.001
CCR	3.56±1.62	4.52±1.87	6.71±2.81	NS	0.001	0.001	0.001
CVRI	2.66±1.08	4.26±1.99	6.11±2.72	0.02	0.001	0.004	0.001

Data are presented as mean±SD, one-way ANOVA and post hoc test; I: Control versus statins, II: Control versus nonstatins, III: Statins versus nonstatins, NS: Not significant, BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, PP: Pulse pressure, MAP: Mean arterial pressure, TC: Total cholesterol, TG: Triglyceride, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, VLDL: Very low-density lipoprotein, AI: Atherogenic index, CCR: Cardiac risk ratio, CVRI: Cardiovascular risk index